Personalized medicine is at cusp of making rapid strides in the global pharmaceuticals market. This novel treatment method would potentially benefit a large population affected by chronic diseases such as diabetes, cancer, respiratory disorders, and neurological disorders. Developing personalized therapy requires understanding the patient’s genetic composition, identifying a biomarker, and multiplication of cells or tissues. Cell culture is the prominent method for cell growth. Moreover, advancements in cell culture techniques, such as the 3D cell culture, has further encouraged extensive use of this technique in medical research.
Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/219
Researchers monitor cell growth at regular intervals and terminate cell growth when desired growth or number of cells (cell density) is achieved. Manual monitoring of cell culture is time consuming and is associated with high human error risk. Therefore, a device or analyzer that can continuously monitor the cell culture without requiring manual intervention could help reduce error and save time. Electrochemical biosensors and fiber optic biosensors are deployed in cell culture monitoring analyzers, enabling various parameters such as temperature, cell density, and cell growth. Awareness about such automated cell culture monitoring devices and analyzers will spur growth of the cell culture monitoring biosensors market.
The global cell culture monitoring biosensors market was valued at US$ 214.7 million in 2015 and is expected to witness a moderate CAGR of 10.0% during the forecast period (2016 – 2024).
Extensive utilization of cell culture to propel growth of cell culture monitoring biosensors market
Application of cell culture is quite significant and pronounced in every research and product development in the food, pharmaceuticals, and biotechnology sectors, among others. Cell culture technique has enabled quick manufacturing of vaccines and biotechnology products. Moreover, a spike in growth is expected in the biosimilars market, which will further propel demand for cell culture monitoring and hence, the need for biosensors. Personalized medicines is the new drug delivery technique in the global pharmaceutical industry. Cell culture technique is used for identifying potential biomarkers and develop a targeted drug therapy. This requires accurate and continuous monitoring of critical cell culture parameters at regular time interval. Biosensors eases monitoring of cell culture in every process. Growing cell culture applications will boost growth of cell culture monitoring biosensors market.
Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/21
Key companies covered as a part of this study include C-CIT Sensors AG, Sarissa Biomedical Ltd, Lonza, Lifeonics, Nova Biomedical, Conductive Technologies Inc., Nanomedical Diagnostics and Sierra Sensors GmbH.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Subscribe to our newsletter to get notification about new updates,information, discount, etc..